Financial Snapshot

Revenue
$0.00
TTM
Gross Margin
Net Earnings
-$22.75K
TTM
Current Assets
Q4 2024
Current Liabilities
Q4 2024
Current Ratio
0.0%
Q4 2024
Total Assets
Total Liabilities
Book Value
Cash
Q4 2024
P/E
-474.7
Dec 04, 2024 EST
Free Cash Flow

Revenues

Revenues

Revenue YoY Change

No data

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change

Expenses

Cost Of Revenues

No data

Gross Profit

No data

Gross Profit Margin

No data

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost Of Revenue
Gross Profit
Gross Profit Margin

Selling, General & Admin Expense

Research & Development

No data

Depreciation, Depletion & Amortization

No data

SGA Expense to Gross Profit Ratio

No data

R&D To Gross Profit Ratio

No data

DDA To Gross Profit Ratio

No data

Operating Expenses Total

Operating Profits/Loss

No data

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Selling, General & Admin $47.37K $32.53K $32.93K $33.60K $25.36K $40.24K $33.85K $35.65K $33.02K $37.51K
YoY Change 45.62% -1.21% -1.99% 32.49% -36.98% 18.88% -5.05% 7.96% -11.97%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $47.37K $32.53K $32.93K $33.60K $25.36K $40.24K $33.85K $35.65K $33.02K $37.51K
YoY Change 45.62% -1.21% -1.99% 32.49% -36.98% 18.88% -5.05% 7.96% -11.97%
Operating Profit
YoY Change

Interest Expenses

Interest Expenses To Operating Income %

No data

Other Expense/Income

No data

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Interest Expense $300.00 $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

No data

Net Profits/Loss YoY Change

Basic EPS

No data

Net Income To Revenue Ratio

No data

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Pretax Income -$47.67K -$32.53K -$32.93K -$33.60K -$25.36K -$40.24K -$33.85K -$35.65K -$33.02K -$37.51K
YoY Change 46.53% -1.2% -1.99% 32.49% -36.98% 18.88% -5.05% 7.96% -11.97%
Income Tax $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$47.67K -$33.60K -$32.93K -$33.60K -$25.36K -$40.24K -$33.85K -$35.65K -$33.02K -$37.51K
YoY Change 41.88% 2.03% -1.99% 32.49% -36.98% 18.88% -5.05% 7.96% -11.97%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $0.00 -$1.646K -$1.679K -$1.268K -$2.011K -$1.692K -$1.782K -$1.650K -$1.875K

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

No data

Receivables

No data

Total Short-Term Assets

Property, Plant And Equipment

No data

Long-Term Investments

No data

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

No data

Accounts Payable

Short-Term Debt

Long Term Debt Due

No data

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

No data

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

No data

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Cash & Short-Term Investments $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Cash & Equivalents $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Total Assets $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Accounts Payable $5.000K $0.00 $210.00 $0.00 $0.00 $0.00 $0.00 $180.00
YoY Change -100.0% -100.0%
Accrued Expenses $0.00 $11.75K $11.50K $11.50K $11.45K $12.80K
YoY Change -100.0% 2.17% 0.0% 0.44% -10.55%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $429.6K $381.9K $349.4K $316.5K $282.9K $257.5K $217.3K $183.4K $147.8K $114.8K
YoY Change 12.48% 9.31% 10.41% 11.88% 9.85% 18.52% 18.46% 24.13% 28.77%
Long-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Total Liabilities $429.6K $381.9K $349.4K $316.5K $282.9K $257.5K $217.3K $183.4K $147.8K $114.8K
YoY Change 12.48% 9.31% 10.41% 11.88% 9.85% 18.52% 18.46% 24.13% 28.77%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

No data

Preferred Stock

No data

Treasury Stock Shares

No data

Stock Issuance & Repurchase

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Basic Shares Outstanding
Diluted Shares Outstanding 20.01M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

No data

Book Value

Free Cash Flow

No data

Free Cash Flow YoY

No data

Free Cash Flow Margin

No data

Dividends

Dividends

No data

Stock Price

Market Cap: $10.8 Million

About Green Planet Bio Engineering Co. Ltd.

Green Planet Bioengineering Co. Ltd. operates as a shell company, with the purpose of acquisition and merging with an existing business operation. The company is headquartered in Aventura, Florida. The company went IPO on 2009-07-16. The firm is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses. The firm has no ongoing operations and has no revenues.

Industry: Biological Products, (No Diagnostic Substances) Peers: